Venus Remedies Limited (BOM:526953)
1,569.35
-81.25 (-4.92%)
At close: Jul 27, 2026
Venus Remedies Market Cap
Venus Remedies has a market cap or net worth of 20.98 billion as of July 27, 2026. Its market cap has increased by 202.61% in one year.
Market Cap
20.98B
Enterprise Value
20.07B
Revenue
8.11B
Ranking
n/a
PE Ratio
18.06
Stock Price
1,569.35
ChartMarket Cap Chart
Since October 19, 2004, Venus Remedies's market cap has increased from 242.83M to 20.98B, an increase of 8,538.65%. That is a compound annual growth rate of 22.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 20.98B | 104.61% |
| Dec 31, 2025 | 10.25B | 139.58% |
| Dec 31, 2024 | 4.28B | -21.14% |
| Dec 29, 2023 | 5.43B | 124.10% |
| Dec 30, 2022 | 2.42B | -55.77% |
| Dec 31, 2021 | 5.48B | 194.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Unichem Laboratories | 37.97B |
| Gufic Biosciences | 37.93B |
| Morepen Laboratories | 29.47B |
| Kwality Pharmaceuticals | 28.81B |
| Hikal | 26.78B |
| TTK Healthcare | 14.82B |
| Fredun Pharmaceuticals | 14.80B |
| Amrutanjan Health Care | 14.76B |